Field Medical Secures $40 Million Series A Funding to Transform Ventricular Tachycardia Treatment
Deal News | Apr 22, 2025 | PR Newswire Cision Field Medical, Inc.
Field Medical Inc., a leader in pulsed field ablation (PFA) technology, has successfully closed a $40 million Series A funding round. This funding includes $20 million in new capital and the conversion of $20 million in startup debt. The investment, supported by major strategic partners, venture capital firms, and family offices, underlines substantial confidence in Field Medical's focus on ventricular tachycardia (VT) and its broader potential with the PFA technology. The funding will drive two pilot studies and support the development of Field Medical's PFA commercial system, moving towards its pivotal trial, VERITAS. The company, led by Dr. Steven Mickelsen, aims to revolutionize cardiac ablation therapy and expand access to next-generation technologies. The ablation system is experimental, but the company is prepared for significant market growth amidst widespread ventricular tachycardia and atrial fibrillation, which afflict millions worldwide.
Sectors
- Medical Devices
- Venture Capital
Geography
- United States – Field Medical is located in Cardiff-by-the-Sea, California, and operates within the U.S. healthcare market.
- Europe – The article mentions the prevalence of cardiac arrhythmias in Europe, indicating a significant market for Field Medical's products.
Industry
- Medical Devices – Field Medical operates in the medical devices industry, focusing on cardiac ablation technology using pulsed field ablation for treating cardiac arrhythmias.
- Venture Capital – The article discusses a significant Series A funding round involving venture capital firms to support the development of Field Medical's technology.
Financials
- $40 million – Total amount raised in Field Medical's Series A funding round.
- $20 million – Amount of new capital raised in the Series A round.
- $20 million – Debt converted into equity during the Series A round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Field Medical Inc. | Target Company | Company | A medical device company pioneering pulsed field ablation technology for cardiac treatments. |
| Steven Mickelsen, M.D. | CEO and Founder | Person | Founder and CEO of Field Medical, leading innovations in PFA technology for cardiac ablation. |
| Oskar Dadason | Chief Financial Officer | Person | CFO of Field Medical, overseeing the financial strategy and Series A funding round. |
| Holly Windler | Media Relations | Person | Handles media relations for Field Medical. |
| Venture Capital Firms and Family Offices | Investors | Company | Provided funding for Field Medical’s Series A round. |